Michael is a seasoned leader in Market Access, HTA, HEOR, and pharmaceutical operations, with nearly 30 years of industry experience in Canadian and global roles. He has spent 15+ years in brand pharma and 10+ years in consulting, holding several Director-level and above positions. Michael specializes in shaping value propositions, payer strategies, and reimbursement pathways for both public and private formularies. His expertise spans multiple therapeutic areas, including market access leadership of top pharmaceutical and biologic brands.
Established in 2020, Pharmacoevidence has grown into a recognized leader in pharmaceutical research, guided by a steadfast focus on innovation and patient well‑
Pharmacoevidence’s Generative AI Products empower life sciences organizations to generate high-quality evidence with speed and precision. From automated SLRs to HTA review simulations, our intelligent platforms minimize manual effort, enhance analytical accuracy, and support strategic market access decisions.
